Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry
文献类型:期刊论文
作者 | Liang, Wenhua1,2,3; He, Jiaxi1,2,3; Shen, Yaxing7; Shen, Jianfei1,2,3,6; He, Qihua1,2,3; Zhang, Jianrong1,2,3; Jiang, Gening8; Wang, Qun7; Liu, Lunxu10; Gao, Shugeng11,12,13 |
刊名 | JOURNAL OF CLINICAL ONCOLOGY
![]() |
出版日期 | 2017-04-10 |
卷号 | 35期号:11页码:1162-1170 |
ISSN号 | 0732-183X |
DOI | 10.1200/JCO.2016.67.5140 |
英文摘要 | Purpose We investigated the correlation between the number of examined lymph nodes (ELNs) and correct staging and long-term survival in non-small-cell lung cancer (NSCLC) by using large databases and determined the minimal threshold for the ELN count. Methods Data from a Chinese multi-institutional registry and the US SEER database on stage I to IIIA resected NSCLC (2001 to 2008) were analyzed for the relationship between the ELN count and stage migration and overall survival (OS) by using multivariable models. The series of the mean positive LNs, odds ratios (ORs), and hazard ratios (HRs) were fitted with a LOWESS smoother, and the structural break points were determined by Chow test. The selected cut point was validated with the SEER 2009 cohort. Results Although the distribution of ELN count differed between the Chinese registry (n = 5,706) and the SEER database (n = 38,806; median, 15 versus seven, respectively), both cohorts exhibited significantly proportional increases from N0 to N1 and N2 disease (SEER OR, 1.038; China OR, 1.012; both P < .001) and serial improvements in OS (N0 disease: SEER HR, 0.986; China HR, 0.981; both P < .001; N1 and N2 disease: SEER HR, 0.989; China HR, 0.984; both P,.001) as the ELN count increased after controlling for confounders. Cut point analysis showed a threshold ELN count of 16 in patients with declared node-negative disease, which were examined in the derivation cohorts (SEER 2001 to 2008 HR, 0.830; China HR, 0.738) and validated in the SEER 2009 cohort (HR, 0.837). Conclusion A greater number of ELNs is associated with more-accurate node staging and better long-term survival of resected NSCLC. We recommend 16 ELNs as the cut point for evaluating the quality of LN examination or prognostic stratification postoperatively for patients with declared node-negative disease. (C) 2016 by American Society of Clinical Oncology. |
资助项目 | Science and Technology Planning Project of Guangdong Province, People's Republic of China[2007B031515017] ; Science and Technology Planning Project of Guangdong Province, People's Republic of China[2008A030201024] ; Science and Technology Planning Project of Guangzhou, People's Republic of China[2007Z1-E0111] ; Science and Technology Planning Project of Guangzhou, People's Republic of China[2007Z3-E0261] ; Guangzhou Health and Medical Collaborative Innovative Major Special Projects[201400000001-2] ; Guangdong Doctoral Launching Program[2014A030310460] ; Doctoral Launching Program of Guangzhou Medical University[2014C27] ; Chinese National Natural Science Foundation[81501996] |
WOS研究方向 | Oncology |
语种 | 英语 |
WOS记录号 | WOS:000398351600006 |
出版者 | AMER SOC CLINICAL ONCOLOGY |
源URL | [http://ir.amss.ac.cn/handle/2S8OKBNM/24970] ![]() |
专题 | 系统科学研究所 |
通讯作者 | He, Jianxing |
作者单位 | 1.Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China 2.Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China 3.China State Key Lab Resp Disease, Guangzhou, Guangdong, Peoples R China 4.Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China 5.Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China 6.Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Linhai, Peoples R China 7.Fudan Univ, Shanghai Zhongshan Hosp, Shanghai, Peoples R China 8.Tongji Univ, Shanghai Pulm Hosp, Shanghai, Peoples R China 9.Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China 10.Sichuan Univ, West China Hosp, Chengdu, Peoples R China |
推荐引用方式 GB/T 7714 | Liang, Wenhua,He, Jiaxi,Shen, Yaxing,et al. Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry[J]. JOURNAL OF CLINICAL ONCOLOGY,2017,35(11):1162-1170. |
APA | Liang, Wenhua.,He, Jiaxi.,Shen, Yaxing.,Shen, Jianfei.,He, Qihua.,...&He, Jianxing.(2017).Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.JOURNAL OF CLINICAL ONCOLOGY,35(11),1162-1170. |
MLA | Liang, Wenhua,et al."Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry".JOURNAL OF CLINICAL ONCOLOGY 35.11(2017):1162-1170. |
入库方式: OAI收割
来源:数学与系统科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。